Business ＆ Technology
IP Generator for mRNA therapeutics
Implementation System for mRNA Drug Discovery
AXCELEAD Group Forms Business and Capital Alliance with IPGaia
Equivalent to the mRNA medicine discovery divisions of major pharmaceutical companies or Western bio-ventures
Established R&D and business development of mRNA medicines on a 70-80 person scale
Partner
Drug discovery solution provider
Global-level drug discovery capabilities inherited from Takeda
Joint Venture of Axcelead and Arcturus
Asia Pacific GMP-compliant integrated mRNA medicine CDMO
Game-changer for drug discovery
Platformer that accelerates the speed of bringing non-clinical research assets to market
